Skip to content

A clinical trial to study the effect of remote ischemic preconditioning on inflammatory markers in STEMI patients undergoing primary PCI

COMPARATIVE EVALUATION OF EFFECT OF REMOTE ISCHEMIC PRECONDITIONING ON INFLAMMATORY MARKERS IN STEMI PATIENTS UNDERGOING PRIMARY PCI AND ITS CORRELATION WITH SERUM VITAMIN D LEVELS - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/058123
Enrollment
120
Registered
2023-09-29
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I213- ST elevation (STEMI) myocardial infarction of unspecified site

Interventions

Intervention1: REMOTE ISCHEMIC PRECONDITIONING: Patients will be randomized to primary PCI alone or RIPC with primary PCI. RIPC will be done with an automated cuff placed on the right upper arm and in

Sponsors

All India Institute of Medical Sciences New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients with STEMI undergoing primary PCI 2) Age > 18 years 3) Window period less than 12 hours

Exclusion criteria

Exclusion criteria: 1) Patients below 18 years 2) History of Coronary artery bypass grafting (CABG) 3) Post CPR status 4) Previous MI 5) Those on allopurinol/ nicorandil 6) Patients with cardiogenic shock 7) Those who cannot give consent

Design outcomes

Primary

MeasureTime frame
Difference in the levels of inflammatory markers (IL-6, IL-8, IL-10, IL-33, CRP, IFN gamma) before and 24 hours after PCI in control and RIPC arm.Timepoint: At the time of enrolment and 24 hours post PCI.

Secondary

MeasureTime frame
Comparison of the following outcomes between the RIPC and control arm: 1. Difference in survival at 30 days 2. Difference in non-fatal MACE at 30 day Timepoint: 30 days after enrollment

Countries

India

Contacts

Public ContactDr D Chidanand

All India Institute of Medical Sciences New Delhi 110029

hnyadav@gmail.com8171544655

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026